World Pharma News


AbbottAbbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 83,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's website at

Abbott RSS Channel

Display # 
Title Published Date
Abbott completes acquisition of Veropharm 12 December 2014
Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan 14 July 2014
Abbott to acquire Veropharm 23 June 2014
Abbott enhances its position in fast-growing Latin American market 18 May 2014
Abbott reports first-quarter 2014 results 16 April 2014
Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China 10 April 2014
Abbott reports fourth-quarter and full-year 2013 results 22 January 2014
Experience a day in the life of an insulin-using patient with diabetes through interactive infographic 14 November 2013
Abbott reports third-quarter 2013 results 16 October 2013
Abbott reports first-quarter 2013 results 17 April 2013
Abbott to collaborate with Janssen and Pharmacyclics 21 February 2013
Abbott initiates clinical trial of Absorb TM in the United States 08 January 2013
Abbott completes separation of research-based pharmaceuticals business 02 January 2013
Abbott announces three-year long-term data evaluating efficacy with HUMIRA® (Adalimumab) 22 October 2012
Abbott reports double digit earnings per share growth in the third quarter 17 October 2012
Abbott's HUMIRA® (adalimumab) receives FDA approval for the treatment of ulcerative colitis 30 September 2012
Abbott announces international launch of the Absorb(TM) 25 September 2012
Abbott to collaborate with Astellas in CMV vaccine trial 06 September 2012
Abbott reports second quarter results 18 July 2012
Abbott introduces OneLab, a novel integrated web-based software platform 11 July 2012

© World Pharma News 2006 - 2015

Top Desktop version